Philip Rosenfeld, MD
Retina Specialist · Miami, FLNPI 1285659722
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $143,413 of the $205,873 with a category attached, or 69.7%. Carl Zeiss Meditec, Inc. accounts for 72.0% of it on its own, with 13 other manufacturers making up the rest. Among retina specialist clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 89 payments — averaging $2313.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Carl Zeiss Meditec, Inc.$148K
- Apellis Pharmaceuticals, Inc.$18K
- Regeneron$10K
- Boehringer Ingelheim$10K
- F. Hoffmann-la Roche AG$6K
- Eyepoint US, Inc.$5K
- plus $8K from 8 others
Across 11 payments — averaging $7916.85 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AstraZeneca$39K
- Novartis$31K
- Boehringer Ingelheim$17K
- Boehringer Ingelheim Pharma GmbH & Co.kg$367
What the payments were for
- Consulting fees$143,41370%
- Speaking & faculty fees$23,76812%
- Travel & lodging$36,88018%
- Food & beverage$1,7971%
- Education$150%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Carl Zeiss Meditec, Inc. | 34 | $148,221 |
| Apellis Pharmaceuticals, Inc. | 18 | $18,425 |
| Regeneron | 11 | $10,453 |
| Boehringer Ingelheim | 6 | $10,342 |
| F. Hoffmann-la Roche AG | 2 | $5,819 |
| Eyepoint US, Inc. | 3 | $4,640 |
| Biogen | 1 | $2,975 |
| Boehringer Ingelheim International GmbH | 3 | $2,550 |
| AbbVie | 2 | $1,600 |
| Bausch & Lomb Americas Inc. | 2 | $471 |
| Genentech, Inc. | 1 | $146 |
| Johnson & Johnson Surgical Vision, Inc. | 1 | $116 |
| Genentech USA, Inc. | 4 | $89 |
| Regeneron Healthcare Solutions, Inc. | 1 | $27 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PLEX Elite 9000$73,999
- CIRRUS HD-OCT$39,112
- PLEX Elite$37,872
- EYLEA$10,249
- Syfovre$8,785
- CLARUS$8,000
- CIRRUS 6000 with AngioPlex$7,000
- EYP-1901$4,588
- Lucentis$4,285
- VisuMax$2,000
- QUATERA 700$2,000
- CALLISTO eye$2,000
- SUSVIMO$146
- VABYSMO$146
- Tecnis IOL$116
- Clarus 700$112
How this compares
$205,873 in reported general payments places this provider in the 95th percentile of 118 retina specialist providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other retina specialist in Miami
- Thomas AlbiniMiami$281K
- Audina BerrocalMiami$210K
- Nicolas YannuzziMiami$60K
- Hong-Uyen HuaMiami$45K
- Justin TownsendMiami$40K
- Harry FlynnMiami$7K
- Sunil GuptaPensacola$1.8M
- Joseph NezgodaWest Palm Beach$600K
- Eduardo UchiyamaFt Lauderdale$356K
- John MyersPensacola$152K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.